Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cidara Therapeutics to Participate in Upcoming Investor Conferences
-
MyoKardia to Participate in September Investor Conferences
-
XOMA to Present at Upcoming Investor Conferences
-
BrainsWay Announces Presentations at Upcoming Investor Conferences
-
Trevena, Inc. to Present at September Virtual Investor Conferences
-
Affimed to Present at Upcoming Investor Conferences
-
Affimed to Present at Upcoming Investor Conferences
-
ACG Analytics and Makor Oscar Gruss to Form Partnership
-
CF Finance Acquisition Corp. II Announces Closing of $500 Million Initial Public Offering
-
Form 8-K Cantor Fitzgerald Income For: Aug 31
-
Opiant Pharmaceuticals to Participate at the 2020 Cantor Global Virtual Healthcare Conference
-
Opiant Pharmaceuticals to Participate at the 2020 Cantor Global Virtual Healthcare Conference
-
IDEAYA to Participate in Upcoming September 2020 Investor Relations Events
-
FTAC Olympus Acquisition Corp. Announces Completion of $750,000,000 Initial Public Offering
-
FTAC Olympus Acquisition Corp. Announces Completion of $750,000,000 Initial Public Offering
-
Pre-Open Stock Movers 8/28: (IBIO) (NTNX) (TRVN) Higher; (PLT) (BILL) (OKTA) Lower (more...)
-
Stereotaxis to Present at Three Investor Conferences in September
-
Fortress Biotech (FBIO) Announces $60 Million Loan Agreement with Oaktree Capital Management
-
Entasis Therapeutics Holdings Inc. (ETTX) Announces $25 Million Private Placement of Common Stock, Warrants
-
Entasis Therapeutics Announces $25 Million Private Placement
-
Fortress Biotech Announces $60 Million Loan Agreement with Oaktree Capital Management
-
Entasis Therapeutics Announces $25 Million Private Placement
-
Fortress Biotech Announces $60 Million Loan Agreement with Oaktree Capital Management
-
Companies with NDRs 08/28
-
After-Hours Movers 08/27: (NTNX) (ULTA) (WDAY) Higher; (PLT) (BILL) (OKTA) Lower (more...)
-
Cantor Fitzgerald Starts Trevena (TRVN) at Overweight
-
Pamela Bentley to Join GCM Grosvenor
-
Lumos Pharma to Participate in Upcoming Investor Conferences
-
Lumos Pharma to Participate in Upcoming Investor Conferences
-
Companies with NDRs 08/27
-
CF Finance Acquisition Corp. II (CFII) Prices 50M Unit IPO at $10/Unit
-
CF Finance Acquisition Corp. II Announces Pricing of $500 Million Initial Public Offering
-
DURECT Corporation Fireside Chat hosted by Ellie Merle of Cantor Fitzgerald
-
Companies with NDRs 08/26
-
Regeneron Announces Investor Conference Presentations
-
FTAC Olympus Acquisition Corp. (FTOC) Prices 75M Unit IPO at $10/Unit
-
FTAC Olympus Acquisition Corp. Announces Pricing of $750,000,000 Initial Public Offering
-
FTAC Olympus Acquisition Corp. Announces Pricing of $750,000,000 Initial Public Offering
-
Doubts grow Alaska's Pebble Mine can satisfy new regulatory hurdles, shares tumble
-
Nanox Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Vocera to Present at Upcoming Investor Conferences
-
Companies with NDRs 08/25
-
Cresco Labs Announces Upcoming Conference Participation
-
Lionheart Acquisition Corporation II Announces Exercise and Closing of Underwriters’ Over-Allotment Option, Resulting in an Aggregate of $230 Million Being Raised in its IPO
-
Companies with NDRs 08/24
-
Heat Biologics (HTBX) Adds Cantor Fitzgerald as Additional Sale Agent for $100M ATM Offering
-
Nomad Royalty Company to Acquire Coral Gold, Marking the Start of Its Sector Consolidation Strategy
-
NANO-X IMAGING LTD (NNOX) Prices 9.18M Share Upsized IPO at $18/Sh
-
Nanox Announces Pricing of Upsized Initial Public Offering
-
Trilogy Metals (TMQ:CN) (TMQ) PT Lowered to Cdn$4.50 at Cantor Fitzgerald, Following Earnings

